z-logo
open-access-imgOpen Access
What now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives?
Author(s) -
R. E. J. Ryder,
Ralph A. DeFronzo
Publication year - 2017
Publication title -
british journal of diabetes
Language(s) - English
Resource type - Journals
eISSN - 2397-6241
pISSN - 2397-6233
DOI - 10.15277/bjd.2017.036
Subject(s) - liraglutide , pioglitazone , metformin , medicine , diabetes mellitus , complement (music) , pharmacology , endocrinology , type 2 diabetes , chemistry , biochemistry , complementation , phenotype , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom